INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $618,000 | +122.3% | 7,366 | +62.6% | 0.02% | +112.5% |
| Q1 2018 | $278,000 | -72.3% | 4,530 | -50.9% | 0.01% | -75.8% |
| Q4 2016 | $1,002,000 | -44.9% | 9,222 | -16.6% | 0.03% | -45.0% |
| Q3 2016 | $1,820,000 | +787.8% | 11,060 | +706.1% | 0.06% | +757.1% |
| Q4 2015 | $205,000 | -5.5% | 1,372 | +5.1% | 0.01% | -12.5% |
| Q3 2015 | $217,000 | -37.5% | 1,306 | -9.1% | 0.01% | -33.3% |
| Q2 2015 | $347,000 | -21.1% | 1,437 | -7.9% | 0.01% | -20.0% |
| Q1 2015 | $440,000 | – | 1,560 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |